Kennedy Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Kennedy Capital Management's CSTL Position: Q3 2026 in Review
Kennedy Capital Management reduced its Castle Biosciences (CSTL) stake by 2.6% in Q3 2026, selling an estimated $275K and leaving 339,263 shares worth $12.1M. The position accounts for 0.23% of the portfolio, ranked #153.
Kennedy Capital Management first reported a position in CSTL in Q2 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Kennedy Capital Management held 339,263 shares of Castle Biosciences worth $12.1M as of Q3 2026.
- Kennedy Capital Management sold 9,108 Castle Biosciences shares in Q3 2026, an estimated $275K.
- Castle Biosciences made up 0.23% of Kennedy Capital Management's portfolio in Q3 2026, its #153 holding.
- Kennedy Capital Management first reported a position in Castle Biosciences in Q2 2026 and has held it in 2 quarters since.
- 201 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.